EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The GDF15 3′ UTR Polymorphism rs1054564 Is Associated with Diabetes and Subclinical Atherosclerosis

Montse Guardiola iD, Josefa Girona iD, Emma Barroso iD, María García-Altares, Daiana Ibarretxe, Núria Plana, Josep Ribalta iD, Xavier Correig iD, Manuel Vázquez-Carrera iD, Lluís Masana iD, Ricardo Rodríguez-Calvo iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252211985 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Montse Guardiola und 10 weiteren Autor:innen. Beteiligte Einrichtung: Research Unit on Lipids and Atherosclerosis, Universitat Rovira i Virgili, 43201 Reus, Spain. Hauptthemen laut MEDLINE: Growth Differentiation Factor 15, Polymorphism, Single Nucleotide, Atherosclerosis, 3' Untranslated Regions. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas, CIBER (Consorcio Centro de Investigación Biomédica en Red), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Growth differentiation factor 15 (GDF15) is a stress-response cytokine related to a wide variety of metabolic diseases. However, the impact of GDF15-specific genetic variants on the abovementioned conditions is poorly known. The aim of this study was to assess the impact of selected GDF15 single-nucleotide polymorphisms (SNPs) on metabolic disturbances and subclinical atherosclerosis. A cross-sectional study involving 153 participants of a metabolic patient-based cohort was performed. Three selected SNPs (rs888663, rs1054564 and rs1059369) in a locus on chromosome 19 including the GDF15 gene were genotyped by Polymerase Chain Reaction (PCR), and its relationship with the serum GDF15 levels, health status and clinical variables were analyzed. Of the three SNPs analyzed, only rs1054564 showed different distributions between the healthy volunteers and patients suffering lipid alterations and associated disorders. Accordingly, just the rs1054564 variant carriers showed a significant increase in GDF15 serum levels compared to the wild-type carriers. The group of variant carriers showed a higher frequency of individuals with diabetes, compared to the wild-type carrier group, without showing differences in other metabolic conditions. Additionally, the frequency of individuals with atherosclerotic carotid plaque was higher in the rs1054564 variant carriers than in the wild-type carriers. Logistic regression models identified that the presence of the rs1054564 variant carriers increase the likelihood for both diabetes and carotid plaque independently of confounding factors. Overall, the findings of this study identify the rs1054564 variant as a potential indicator for the likelihood of diabetes and subclinical atherosclerosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Growth Differentiation Factor 15Polymorphism, Single NucleotideAtherosclerosis3' Untranslated RegionsGenetic Predisposition to DiseaseHumansMaleFemaleMiddle AgedAgedCross-Sectional StudiesDiabetes MellitusGenotypeAdult

Stichwörter der Autor:innen

GDF15atherosclerosisdiabetesrs1054564

Substanzen

Growth Differentiation Factor 15GDF15 protein, human3' Untranslated Regions

Autor:innen und Institutionen

  • Research Unit on Lipids and Atherosclerosis, Universitat Rovira i Virgili, 43201 Reus, Spain.
  • Vascular Medicine and Metabolism Unit, "Sant Joan de Reus" University Hospital, 43204 Reus, Spain.
  • Pere Virgili Health Research Institute (IISPV), 43007 Tarragona, Spain.
  • Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), Institute of Health Carlos III, 28029 Madrid, Spain.
  • Pharmacology Unit, Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain.
  • Institut de Biomedicina de la Universidad de Barcelona (IBUB), University of Barcelona, 08028 Barcelona, Spain.

ORCID-Profile: Montse Guardiola, Josefa Girona, Emma Barroso, Josep Ribalta, Xavier Correig, Manuel Vázquez-Carrera, Lluís Masana, Ricardo Rodríguez-Calvo

Förderung

  • Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas
  • CIBER (Consorcio Centro de Investigación Biomédica en Red)
  • Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación
  • the MICIU/AEI/10.13039/501100011033 and “ERDF, A Way of making Europe”

Zitieren

APA

Guardiola, M., Girona, J., Barroso, E., García-Altares, M., Ibarretxe, D., Plana, N., Ribalta, J., Correig, X., Vázquez-Carrera, M., Masana, L., & Rodríguez-Calvo, R. (2024). The GDF15 3′ UTR Polymorphism rs1054564 Is Associated with Diabetes and Subclinical Atherosclerosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252211985

Vancouver

Guardiola M, Girona J, Barroso E, García-Altares M, Ibarretxe D, Plana N, et al. The GDF15 3′ UTR Polymorphism rs1054564 Is Associated with Diabetes and Subclinical Atherosclerosis. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252211985

BibTeX
@article{Guardiola2024,
  author = {Guardiola, Montse and Girona, Josefa and Barroso, Emma and García-Altares, María and Ibarretxe, Daiana and Plana, Núria and Ribalta, Josep and Correig, Xavier and Vázquez-Carrera, Manuel and Masana, Lluís and Rodríguez-Calvo, Ricardo},
  title = {The GDF15 3′ UTR Polymorphism rs1054564 Is Associated with Diabetes and Subclinical Atherosclerosis},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252211985}
}
Kostenlos starten →